Published Sep 29, 2026 | 7:00 AM ⚊ Updated Sep 29, 2026 | 7:00 AM
Government data show that a cardiovascular hospitalisation in India costs an average of ₹55,870.
Synopsis: New NSS data show that an average cardiovascular hospitalisation costs ₹55,870 in India, rising to ₹80,435 in private hospitals. Doctors say advanced technologies, procedures and intensive care are driving expenditure, but the financial burden extends beyond discharge through medicines, follow-ups, rehabilitation, lost income and other recurring costs.
A heart problem can begin with a sudden pain in the chest, a rush to the hospital and a series of decisions that have to be made quickly. For families, however, the financial consequences can continue long after the emergency has passed.
New government data show that a cardiovascular hospitalisation in India costs an average of ₹55,870 when all types of healthcare institutions are considered. In private hospitals, the average expenditure rises to ₹80,435.
The figures come from the 80th Round of the National Sample Survey (NSS), which captured medical expenditure per hospitalisation for cardiovascular diseases across rural and urban India. The survey covered more than 9,000 sample cases representing around 38.1 lakh hospitalisations nationally.
The numbers also show how sharply expenditure can vary depending on where a patient receives treatment. The average expenditure in government hospitals was ₹10,379, compared with ₹80,435 in private hospitals.
But doctors say the numbers should not simply be read as evidence that cardiac hospitals are charging more. They also reflect the growing availability of sophisticated cardiac procedures, devices, intensive care and specialised treatment.
Also Read: When patented drugs become unaffordable, government can intervene: Kerala High Court
“South India has seen the rapid growth of state-of-the-art hospitals, with much greater access to modern cardiac technology and advanced treatment options,” said Dr Niranjan Hiremath, cardiovascular and aortic surgeon at Apollo Hospitals, Jayanagar, Bengaluru to South First.
Hospitals today have access to newer devices, surgical and interventional technologies and more sophisticated intensive-care facilities, he said. Many of these technologies can cost considerably more than older alternatives.
“At the same time, more surgeons and cardiologists are being trained in these newer techniques, so their use is increasing,” Hiremath said.
This means a higher hospitalisation expenditure does not necessarily indicate that patients are suffering from more severe disease or that hospitals are simply charging more, he said.
“It can also reflect the fact that patients now have access to more advanced investigations and treatments than they did previously.”
The NSS data illustrate the variation. Private-sector expenditure for a cardiovascular hospitalisation was ₹1,27,310 in Telangana, ₹1,18,604 in Tamil Nadu, ₹1,05,678 in Kerala and ₹1,04,440 in Andhra Pradesh. Karnataka recorded ₹80,079.
These figures represent average medical expenditure per hospitalisation, not a fixed price for treating a heart attack and not necessarily the amount paid out of pocket by a patient.
A cardiac hospital bill is rarely about one procedure alone.
“The cost of treating a heart attack is made up of several components,” Hiremath said. These include investigations before treatment, the procedure itself, devices, intensive or coronary-care monitoring, medicines, laboratory investigations and the hospital stay.
A patient may undergo coronary angiography and, if required, angioplasty with stenting. The procedure and specialised devices can form a significant part of the bill.
“But it is not just the cost of the stent or angioplasty,” Hiremath said. “The overall bill is a combination of the procedure, devices, investigations, ICU care, medicines and hospitalisation.”
Dr Vivek Jawali, chairman of cardiac sciences at Fortis Hospitals, Bengaluru, similarly said a heart-attack admission can involve ECGs, blood tests, imaging and other investigations before a treatment decision is made.
Some patients may require angiography followed by angioplasty and stenting, while others may need intensive or coronary-care monitoring, medicines and longer hospital stays.
“The final bill can vary considerably depending on the severity of the heart attack, the complexity of the intervention, devices and disposables to be bought and whether complications arise,” Jawali told South First.
The same diagnosis can result in very different hospital bills.
A relatively straightforward admission or uncomplicated angioplasty can have a very different cost from a patient who arrives with a major heart attack and develops complications.
A patient with other conditions such as renal dysfunction, stroke or heart failure may require prolonged intensive care, ventilation, additional investigations or multiple procedures. Each of these can add to the expenditure.
“There is no single ‘cost of a heart attack’,” Hiremath said. “The final expenditure depends greatly on the severity of the disease, the patient’s other medical conditions, the procedures required and the duration of hospitalisation.”
Jawali also pointed to the difference between a planned procedure and an emergency cardiac event.
The NSS numbers show substantial differences between states, but they cannot by themselves explain why those differences exist.
Hiremath said the growing use of newer technologies is one factor.
“Some of the newer and more sophisticated devices used in cardiovascular procedures are imported, and there are associated handling, logistics and import-related costs,” he said.
Corporate hospital infrastructure and services also contribute to the overall expenditure, he added.
“Inflation is certainly one component of the increase in healthcare costs, but it is not the only factor. The availability and use of newer technologies and imported devices also contribute.”
Jawali cautioned against interpreting higher expenditure simply as higher hospital prices.
Private cardiovascular hospitalisation costs, he said, are broadly comparable across different parts of India, although expenditure varies according to the complexity of the condition, treatment required and duration of hospitalisation.
South India has a well-established network of specialist cardiac centres, he said, giving patients access to investigations, angiography, angioplasty, stenting, heart surgery and intensive care.
“Therefore, higher expenditure may reflect the complexity of care and access to advanced treatment, rather than simply higher hospital prices,” Jawali said.
Telangana provides an illustration of how the overall average can be shaped by both the level of expenditure and where patients receive care.
The NSS puts average cardiovascular hospitalisation expenditure across all institutions in Telangana at ₹95,095, compared with ₹55,870 nationally. In the private sector, Telangana’s figure rises to ₹1,27,310, against the national private-sector average of ₹80,435.
The survey also indicates that 73.7% of cardiovascular hospitalisations in Telangana were in private hospitals, compared with 61.6% nationally.
That means Telangana not only has a higher private-sector expenditure figure, but also a larger share of cardiovascular hospitalisations occurring in private hospitals.
An indicative calculation suggests that Telangana’s higher hospitalisation costs, rather than its greater reliance on private hospitals, account for most of the difference between the state’s average expenditure and the national average. However, the estimate is based on rounded survey data and should not be treated as a causal finding.
The broader point is that the financial burden cannot be understood simply by looking at the private hospital bill in isolation. The type of facility in which patients receive care also influences the overall expenditure captured by the survey.
The contrast with government hospitals is striking.
Nationally, average cardiovascular hospitalisation expenditure in government institutions was ₹10,379, compared with ₹80,435 in private hospitals.
Some southern states report even lower government-sector averages. Telangana recorded ₹3,072 and Tamil Nadu ₹1,396.
These figures, however, need to be interpreted cautiously because state-level estimates for particular institution types can be based on relatively small samples. They should not be treated as a universal price for cardiac treatment in government hospitals.
The NSS figures are also expenditure estimates for hospitalisations represented in the survey. They do not tell us what every patient pays, nor do they capture the entire economic burden of cardiovascular disease.
And that distinction becomes important once the patient leaves the hospital.
Also Read: Dirtier the air, the faster kidney function slipped, reveals study conducted in Chennai and Delhi
For families, the hospital bill may be the most visible expense, but it is only one part of the financial burden.
“Families often focus on the immediate hospital bill and may not adequately account for the costs that continue after discharge,” Hiremath said.
These can include long-term medicines, follow-up consultations, blood tests, repeat investigations and imaging, cardiac rehabilitation and dietary or lifestyle changes.
There are also costs that do not appear on a hospital invoice.
Patients may need to take time away from work. Family members may have to accompany them for repeated appointments. There can be transportation expenses and, in some cases, loss of income during recovery.
“For patients who have undergone angioplasty, major cardiac surgery or treatment for a complicated heart attack, follow-up and medication may continue for years,” Hiremath said.
“The true financial burden of cardiovascular disease is not just the hospitalisation cost; it is the long-term cost of living with and managing cardiovascular disease.”
The NSS data capture an important but limited part of the financial burden of heart disease.
For patients and families the question remains simpler: how much of this can they afford?
Jawali said affordability is a particularly important concern for families without comprehensive health insurance. The immediate hospitalisation can be followed by recurring expenses for medicines, investigations and follow-up care.
As cardiac medicine becomes increasingly capable of treating patients who once had fewer options, the financial question is becoming part of the larger story of access to care.
Advanced technology can save lives. But for the patient, the cost of reaching that technology can extend well beyond the hospital gate.
(Edited by Fayisa CA)
